Antiviral Immunity in HIV-1 infected long term non-progressors (LTNPs).

Détails

ID Serval
serval:BIB_563B016FEAEB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Antiviral Immunity in HIV-1 infected long term non-progressors (LTNPs).
Périodique
Seminars in Virology
Auteur⸱e⸱s
Pantaleo G, Vaccarezza M, Graziosi C, Cohen OJ, Fauci AS
ISSN
1044-5773
Statut éditorial
Publié
Date de publication
1996
Volume
7
Numéro
2
Pages
131-138
Langue
anglais
Résumé
Now that the acquired immunodeficiency syndrome (AIDS) epidemic is well into its second decade, it has become evident that a small percentage (approximately 5%) of HIV-infected individuals do not experience progression of HIV disease even after several years of being infected with HIV. These individuals have been designated as 'long term non-progressors' (LTNPs). From a virologic standpoint, these LTNPs have low viral burden in mononuclear cells, but persistent virus replication as manifested by chronic and generally low levels of plasma viremia. From an immunologic standpoint, immune functions including CD8(+) T-cell- and CD4(+) T-cell-mediated functions are preserved. In addition, they show a vigorous humoral immune response. More importantly, lymphoid tissue structure and function are preserved in LTNPs. Despite persistent low-level virus replication and chronic stimulation of the immune system, immune activation is qualitatively and quantitatively different in LTNPs compared to that observed in HIV-infected individuals whose HIV disease has progressed.
Web of science
Création de la notice
25/02/2013 15:07
Dernière modification de la notice
20/08/2019 15:10
Données d'usage